Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma.

× No keyword cloud information.

12 in total

1. Clinical features and practical diagnosis of bullous pemphigoid.

Authors: Enno Schmidt; Rocco della Torre; Luca Borradori
Journal: Immunol Allergy Clin North Am Date: 2012-04-17 Impact factor: 3.479

2. Bullous pemphigoid--a report of 86 cases from Taiwan.

Authors: Y T Chang; H N Liu; C K Wong
Journal: Clin Exp Dermatol Date: 1996-01 Impact factor: 3.470

3. Immunoblot analysis of autoantigens in localized pemphigoid and pemphigoid nodularis.

Authors: Y Kawahara; K Matsumura; T Hashimoto; T Nishikawa
Journal: Acta Derm Venereol Date: 1997-05 Impact factor: 4.437

4. Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions.

Authors: George Jour; Isabella C Glitza; Rachel M Ellis; Carlos A Torres-Cabala; Michael T Tetzlaff; Janet Y Li; Priyadharsini Nagarajan; Auris Huen; Phyu P Aung; Doina Ivan; Carol R Drucker; Victor G Prieto; Ronald P Rapini; Anisha Patel; Jonathan L Curry
Journal: J Cutan Pathol Date: 2016-05-08 Impact factor: 1.587

Review 5. A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?

Authors: K T Amber; J Zikry; M Hertl
Journal: HLA Date: 2017-01-19 Impact factor: 4.513

6. Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis.

Authors: T Krenacs; G Kiszner; E Stelkovics; P Balla; I Teleki; I Nemeth; E Varga; I Korom; T Barbai; V Plotar; J Timar; E Raso
Journal: Histochem Cell Biol Date: 2012-06-12 Impact factor: 4.304

7. HLA-DQB1*0301 association with increased cutaneous melanoma risk.

Authors: J E Lee; J D Reveille; M I Ross; C D Platsoucas
Journal: Int J Cancer Date: 1994-11-15 Impact factor: 7.396

Review 8. A case report of bullous pemphigoid associated with a melanoma and review of the literature.

Authors: Kyle T Amber; Christine M Panganiban; Dorota Korta; Sebastien de Feraudy; Kristen M Kelly; Sergei A Grando
Journal: Melanoma Res Date: 2017-02 Impact factor: 3.599

9. Antibasement membrane zone antibodies in localized pretibial pemphigoid.

Authors: T Muramatsu; T Iida; T Shirai
Journal: Int J Dermatol Date: 1991-06 Impact factor: 2.736

10. Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma.

Authors: Katharina C Kähler; Jessica C Hassel; Lucie Heinzerling; Carmen Loquai; Rotraut Mössner; Selma Ugurel; Lisa Zimmer; Ralf Gutzmer
Journal: J Dtsch Dermatol Ges Date: 2016-07 Impact factor: 5.584

3 in total

1. Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature.

Authors: Coralie Zumelzu; Marina Alexandre; Christelle Le Roux; Patricia Weber; Alexis Guyot; Annie Levy; Françoise Aucouturier; Sabine Mignot-Grootenboer; Frédéric Caux; Eve Maubec; Catherine Prost-Squarcioni
Journal: Front Med (Lausanne) Date: 2018-09-27

Review 2. The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations.

Authors: Khalaf Kridin; Ralf J Ludwig
Journal: Front Med (Lausanne) Date: 2018-08-20

Review 3. The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.

Authors: Kyle T Amber; Manuel Valdebran; Khalaf Kridin; Sergei A Grando
Journal: Front Med (Lausanne) Date: 2018-07-10

3 in total